- Previous Close
106.95 - Open
109.08 - Bid 109.08 x --
- Ask --
- Day's Range
109.08 - 109.08 - 52 Week Range
84.27 - 231.00 - Volume
1,950 - Avg. Volume
10,102 - Market Cap (intraday)
1.373B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
19.87 - EPS (TTM)
5.49 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India. The company is involved in the production of drugs, medicines, chemicals, foods, etc. It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms. In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic. It also exports its products. The company was incorporated in 1991 and is headquartered in Mumbai, India.
www.lactoseindialimited.com129
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: LACTOSE.BO
View MorePerformance Overview: LACTOSE.BO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LACTOSE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LACTOSE.BO
View MoreValuation Measures
Market Cap
1.35B
Enterprise Value
1.77B
Trailing P/E
19.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.14
Price/Book (mrq)
2.62
Enterprise Value/Revenue
1.50
Enterprise Value/EBITDA
8.41
Financial Highlights
Profitability and Income Statement
Profit Margin
5.86%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.18B
Net Income Avi to Common (ttm)
69.19M
Diluted EPS (ttm)
5.49
Balance Sheet and Cash Flow
Total Cash (mrq)
33.26M
Total Debt/Equity (mrq)
89.27%
Levered Free Cash Flow (ttm)
--